Tuesday December 12, 2017 02:11

Heathcare Press Release : 29 Nov 2017

Jubilant Biosys Announces Successful Achievement of an Early Milestone Related to One of Their Heathcare—29 Nov 17

Jubilant Biosys Ltd. , a Bengaluru-based subsidiary of Jubilant Life Sciences Ltd., announced today that they successfully achieved an early-stage milestone related to a collaborative program with Sanofi in Frankfurt, Germany focused on metabolic

Merck and Pfizer Provide Update on Phase III JAVELIN Gastric 300 Study in Patients With Pre-Treated Heathcare—29 Nov 17

- Pivotal Phase III Javelin trial investigating avelumab as third-line treatment for patients with unresectable, recurrent or metastatic gastric cancer did not meet its pre-specified primary endpoint of superior overall survival compared to

Insightec: The Taiwanese Food and Drug Administration (TFDA) Approved Exablate Neuro for the Heathcare—29 Nov 17

INSIGHTEC , the leader in MR-guided Focused Ultrasound (MRgFUS) therapy, announced today that the Taiwanese Food and Drug Administration (TFDA) has approved its Exablate Neuro system for the treatment of essential tremor in patients who do not respond to

China successfully completes the country#s first human implantation of a retrievable transcatheter Heathcare—29 Nov 17

- The success of the procedure unleashes a new era for retrievable interventional cardiac valve technology in China The first human implantation of the VenusA Plus retrievable valve system was completed successfully at the Second Affiliated Hospital of

Giving Back Made Easy with Smile Train#s New Campaign Heathcare—29 Nov 17

Smile Train launches 'Give Smiles' Campaign on biggest giving day of the year, Giving Tuesday to support children with untreated clefts around the world In celebration of Giving Tuesday and the season of giving, Smile Train, the world's largest cleft

WIRB-Copernicus Group Acquires Vigilare International Heathcare—29 Nov 17

WIRB Copernicus Group(R) (WCG(TM)), the world's leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced its acquisition of Vigilare International, the top provider of integrated, end-to-end